Harrison JA - Search Results

1

Discovery of Pyrazolopyrazines as Selective, Potent, and Mutant-Active MET Inhibitors with Intracranial Efficacy.

Bumpers QA, Pipal RW, Benz-Weeden AM, Brewster JT 2nd, Cook A, Crooks AL, Cruz C, Dwulet NC, Gaudino JJ, Golec D, Harrison JA, Hartley DP, Hassanien SH, Hicken EJ, Kahn D, Laird ER, Lemieux C, Lewandowski N, McCown J, McDonald MG, McNulty O, Mou TC, Nguyen P, Oko L, Opie LP, Otten J, Peck SC, Polites VC, Randall SD, Rosen RZ, Savechenkov P, Simpson H, Singh A, Sparks D, Wickersham K, Wollenberg L, Wong CE, Wong J, Wu WI, Elsayed MSA, Hinklin RJ, Tang TP. Bumpers QA, et al. Among authors: harrison ja. J Med Chem. 2024 Aug 22;67(16):14466-14477. doi: 10.1021/acs.jmedchem.4c01232. Epub 2024 Aug 1. J Med Chem. 2024. PMID: 39088797

2

Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain.

Sloane E, Langer S, Jekich B, Mahoney J, Hughes T, Frank M, Seibert W, Huberty G, Coats B, Harrison J, Klinman D, Poole S, Maier S, Johnson K, Chavez R, Watkins LR, Leinwand L, Milligan E. Sloane E, et al. Gene Ther. 2009 Oct;16(10):1210-22. doi: 10.1038/gt.2009.79. Epub 2009 Jul 2. Gene Ther. 2009. PMID: 19571887 Free PMC article.

3

Caudal granular insular cortex is sufficient and necessary for the long-term maintenance of allodynic behavior in the rat attributable to mononeuropathy.

Benison AM, Chumachenko S, Harrison JA, Maier SF, Falci SP, Watkins LR, Barth DS. Benison AM, et al. Among authors: harrison ja. J Neurosci. 2011 Apr 27;31(17):6317-28. doi: 10.1523/JNEUROSCI.0076-11.2011. J Neurosci. 2011. PMID: 21525272 Free PMC article.

4

A peptide antagonist of the TLR4-MD2 interaction.

Slivka PF, Shridhar M, Lee GI, Sammond DW, Hutchinson MR, Martinko AJ, Buchanan MM, Sholar PW, Kearney JJ, Harrison JA, Watkins LR, Yin H. Slivka PF, et al. Among authors: harrison ja. Chembiochem. 2009 Mar 2;10(4):645-9. doi: 10.1002/cbic.200800769. Chembiochem. 2009. PMID: 19184989 Free PMC article.

5

Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling.

Loram LC, Taylor FR, Strand KA, Harrison JA, Rzasalynn R, Sholar P, Rieger J, Maier SF, Watkins LR. Loram LC, et al. Among authors: harrison ja. Brain Behav Immun. 2013 Oct;33:112-22. doi: 10.1016/j.bbi.2013.06.004. Epub 2013 Jun 28. Brain Behav Immun. 2013. PMID: 23811314 Free PMC article.

6

PEGylation of interleukin-10 for the mitigation of enhanced pain states.

Soderquist RG, Milligan ED, Harrison JA, Chavez RA, Johnson KW, Watkins LR, Mahoney MJ. Soderquist RG, et al. Among authors: harrison ja. J Biomed Mater Res A. 2010 Jun 1;93(3):1169-79. doi: 10.1002/jbm.a.32611. J Biomed Mater Res A. 2010. PMID: 19768789 Free PMC article.

7

Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial priming.

Hains LE, Loram LC, Weiseler JL, Frank MG, Bloss EB, Sholar P, Taylor FR, Harrison JA, Martin TJ, Eisenach JC, Maier SF, Watkins LR. Hains LE, et al. Among authors: harrison ja. J Pain. 2010 Oct;11(10):1004-14. doi: 10.1016/j.jpain.2010.01.271. J Pain. 2010. PMID: 20434956 Free PMC article.

8

Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats.

Hutchinson MR, Ramos KM, Loram LC, Wieseler J, Sholar PW, Kearney JJ, Lewis MT, Crysdale NY, Zhang Y, Harrison JA, Maier SF, Rice KC, Watkins LR. Hutchinson MR, et al. Among authors: harrison ja. Neuroscience. 2009 Dec 29;164(4):1821-32. doi: 10.1016/j.neuroscience.2009.09.046. Epub 2009 Sep 27. Neuroscience. 2009. PMID: 19788917 Free PMC article.

9

Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).

Hutchinson MR, Zhang Y, Brown K, Coats BD, Shridhar M, Sholar PW, Patel SJ, Crysdale NY, Harrison JA, Maier SF, Rice KC, Watkins LR. Hutchinson MR, et al. Among authors: harrison ja. Eur J Neurosci. 2008 Jul;28(1):20-9. doi: 10.1111/j.1460-9568.2008.06321.x. Eur J Neurosci. 2008. PMID: 18662331 Free PMC article.

10

Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders.

Ramos KM, Lewis MT, Morgan KN, Crysdale NY, Kroll JL, Taylor FR, Harrison JA, Sloane EM, Maier SF, Watkins LR. Ramos KM, et al. Among authors: harrison ja. Neuroscience. 2010 Sep 15;169(4):1888-900. doi: 10.1016/j.neuroscience.2010.06.014. Epub 2010 Jun 11. Neuroscience. 2010. PMID: 20547213 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters